Ignite Creation Date:
2024-05-05 @ 5:24 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00446095
Status:
COMPLETED
Last Update Posted:
2016-09-19
First Post:
2007-03-08
Brief Title:
Efficacy and Safety Study of Fostamatinib Tablets to Treat B-cell Lymphoma
Sponsor:
Rigel Pharmaceuticals
Organization:
Rigel Pharmaceuticals
Organization Data
Organization:
Rigel Pharmaceuticals
Class:
INDUSTRY
Study ID:
D4300C00023
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Rigel Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None